Effects of Pramlintide on Endogenous Production of VLDL Triglyceride and Glucose in the Post Prandial State in Type 2 Diabetes Mellitus.
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Pramlintide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 04 Jun 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 04 Jun 2012 Additional lead trial centre(University of Maryland) identified as reported by ClinicalTrials.gov.
- 04 Jun 2012 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.